The Natera settlement benefits consumers who paid out of pocket for Natera noninvasive prenatal screening tests under the names Panorama or Vasistera between Feb. 17, 2016, and Aug. 7, 2025, in Ohio; May 5, 2016, and Aug. 7, 2025, in New Jersey; Feb. 24, 2017, and Aug. 7, 2025, in Florida; April 27, 2017, and Aug. 7, 2025, in New York and Illinois; or Feb. 17, 2018, and Aug. 7, 2025, in all other states.

File a Claim

Deadline to file a claim: 03/23/2026
Proof of Purchase Required: Yes
Potential Individual Reward: $30 minimum payment and above
Total Settlement Amount: $8.25 million
Nationwide

By Top Class Actions | January 27, 2026

Category: Legal News

Follow Article

Blood sample of patient for Non invasive Prenatal Testing test NIPT in laboratory. — (Photo Credit: angellodeco/Shutterstock)

Natera has agreed to an $8.25 million class action lawsuit settlement to resolve claims that it misrepresented the reliability of its noninvasive prenatal screening tests.

Natera is a genetic testing company that offers various tests, including noninvasive prenatal screening tests. These tests are designed to detect genetic disorders in fetuses.

According to the class action lawsuit against Natera resolved by this settlement, the company misrepresents the reliability of its noninvasive prenatal screening tests. Plaintiffs in the case say that, despite Natera’s marketing, these tests do not reliably test for some rare genetic disorders.

The plaintiffs argue that Natera’s false advertising violates consumer protection laws and constitutes a breach of implied warranty.

Natera has not admitted any wrongdoing but agreed to resolve these allegations with an $8.25 million class action settlement.

Under the terms of the Natera prenatal test class action settlement, class members can receive a cash payment based on the amount they paid out of pocket for Natera noninvasive prenatal screening tests.

Class members who submit a claim without proof of purchase can receive up to $30. Class members who submit a claim with proof of purchase can receive up to 10% of their documented proof of purchase if their out-of-pocket costs were greater than $300.

Exact payments will vary depending on the number of participating class members and the amount each class member paid out of pocket for Natera tests.

The deadline for exclusion and objection is March 23, 2026.

The final approval hearing for the Natera class action settlement is scheduled for April 23, 2026.

To receive settlement benefits, class members must submit a valid claim form by March 23, 2026.

Who’s Eligible

Individuals who paid out of pocket, including any copay, co-insurance or deductible, for a Natera noninvasive prenatal screening test under the brand names Panorama or Vasistera between Feb. 17, 2016, and Aug. 7, 2025, in Ohio; May 5, 2016, and Aug. 7, 2025, in New Jersey; Feb. 24, 2017, and Aug. 7, 2025, in Florida; April 27, 2017, and Aug. 7, 2025, in New York and Illinois; and Feb. 17, 2018, and Aug. 7, 2025, in all other states.

Potential Award

$30 minimum payment and above

Proof of Purchase

Claimants must provide documentation of their out-of-pocket expenses for the tests, such as a receipt or an explanation of benefits (EOB) statement from their insurance company. Claimants who submit a claim without proof of purchase will be eligible to receive a payment of up to $30.

Claim Form

CLICK HERE TO FILE A CLAIM »

NOTE: If you do not qualify for this settlement do NOT file a claim.

Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.